Counter-regulation of immune responses mediated by both lipoxins and IDO-dependent mechanisms have been found to be relevant in a growing list of infectious, chronic inflammatory and auto-immune diseases, including toxoplasmosis, HIV infection, leishmaniasis, tuberculosis, cystic fibrosis, asthma and periodontitis [14], [27]. Here, IDO1 is linked to toxoplasmosis.